On March 18, Cancer Genetics, Inc. (CGIX) shares have been seen trading -88.18% off its 52 week- peak value and changed 30.00% from its 52 week-bottom price value. The “percentage off the 52-week high or low” refers to when a stock current price is relative to where it has traded over the last 52 weeks. This gives investors an idea of how much the security has moved in the last year and whether it is trading near the top, middle or bottom of the range.
Volume and Price
Shares of Cancer Genetics, Inc. (CGIX) were valued at $0.26 and moved 2.20% as of a recent closing trade. A total volume of 2.08 million shares were traded versus to average volume of 2.26 million shares.
Relative Strength Index (RSI)
Cancer Genetics, Inc. (CGIX)’s Relative Strength Index (RSI) is 50.50. RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions.
Twenty-day SMA is useful at identifying swing trading trends lasting twenty days. Shorter moving average timeframes are more sensitive to price fluctuations and can pick up on trend changes more quickly than longer-term moving averages. However, these more frequent signals may also result in more “whipsaws”, resulting in erroneous trade signals. CGIX recently closed with rise of 0.80% to its twenty-Day SMA. This short time frame picture represents an upward movement of current price over average price of last twenty days.
Cancer Genetics, Inc. (CGIX) held 41.34 million outstanding shares currently. The company have shares float of 30.96 million. Now have a look at past performance (weekly performance to year to date performance) how Cancer Genetics, Inc. (CGIX) has been moved; whether it performed well or not. CGIX reported a change of 2.65% over the last week and performed 3.59% over the last month while its year to date (YTD) performance revealed an activity trend of 7.44%. The stock’s quarterly performance specifies a shift of -28.77%, and its last twelve month performance is stands at -85.56% while moved -75.24% for the past six months.
Average True Range (14) for Cancer Genetics, Inc. (CGIX) is stands at 0.02. ATR is a volatility indicator. Volatility measures the strength of the price action, and is often overlooked for clues on market direction.
Over the past week, the company showed volatility of 5.54%. Moving out to look at the previous month volatility move, the stock is at 7.16%. A stock with a price that fluctuates wildly, hits new highs and lows or moves erratically is considered highly volatile..
Beta measures volatility or systematic risk, of a stock or a portfolio in comparison to the market as a whole. 1 shows stock moves with market. < 1 means less volatile than market. > 1 indicates more volatile than the market. The stock’s beta is 1.21.
Analyst mean recommendation rating on a stock by the analyst community is at 2.50. Analyst rating score as published on FINVIZ are rated on a 1 to 5 scale. 1 is equivalent to a buy rating, 3 a hold rating, and 5 a sell rating.